Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
- Saba S. Shaikh
- , Yan Zang
- , Janel Hanmer
- , Hong Wang
- , Yan Lin
- , Diwakar Davar
- , Hassane M. Zarour
- , John M. Kirkwood
- , Yana G. Najjar
Research output: Contribution to journal › Article › peer-review
6
Link opens in a new tab
Scopus
citations